PCC030C01C
Pellicon® Capsule with Ultracel® Membrane
pore size 30 kDa, C Screen, size 0.1 m² , with AseptiQuik® G connectors
别名:
Pellicon® Capsule with Ultracel® Membrane
产品名称
Pellicon®胶囊，带Ultracel®膜, Feed: AseptiQuik® G Connector Retentate: AseptiQuik® G Connector Permeate: AseptiQuik® G Connector
material
EPDM rubber seal
PPO/PS blend (core)
PPO/PS blend housing
TPE seal
Ultracel® membrane
composite regenerated cellulose (CRC) membrane
epoxy adhesive
polyester screen
polypropylene screen
polyurethane adhesive
sterility
sterile; γ-irradiated
product line
Pellicon®
storage condition
room temperature (15-30°C)
parameter
4-8 L/min-m2 flow rate (Feed)
50 psi max. transmembrane pressure (3.5 bar) at 4-30 °C (Forward)
75 psi max. inlet pressure (5.1 bar) at 4-30 °C
technique(s)
ultrafiltration: suitable
L
41.1 cm (16.2 in.)
diam.
3.8 cm (1.5 in.)
filtration area
0.1 m2
screen size
, Type C screen (coarse screen)
size
0.1 m2 , with AseptiQuik® G connectors
volume
38 mL , in feed channel
68 mL , in permeate channel
Quality Level
impurities
≤5 ppm Meets TOC (in retentate effluent, after a WFI flush of 20 L/m2)
matrix
Ultracel®
pore size
30 kDa
pH range
2-13
fitting
inlet/outlet connection (Feed: AseptiQuik® G Connector)
inlet/outlet connection (Permeate: AseptiQuik® G Connector)
inlet/outlet connection (Retentate: AseptiQuik® G Connector)
Application
Features and Benefits
Gamma sterilized and preseravtive-free - ready to process in minutes
True single-use, self-contained capusle - fast, safe, and flexible batch turnaround
Proven Ultracel® membrane and C screen - high recovery, superior mass transfer, solvent resistance
Pellicon® TFF proven performance - true linear scalability within Pellicon® TFF families
General description
Other Notes
Comprehensive documentation to support qualification, risk assessment and process optimization needs.
Consolidation of product specific testing, quality and regulatory information to simplify compliance requirements.
Convenient 24/7 access to up-to-date product information.
Packaging
Legal Information
商品
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
What antibody drug conjugates are, how bioconjugates work, design considerations and ADC services for ADC manufacturing, including bioconjugation.
Our overview of scalable tangential flow filtration for viral vector production will provide key considerations for developing and optimizing your downstream process.
Find best practices for using Pellicon® Capsules in ADC processing as well as data from two studies using Pellicon® Capsules and Pellicon® cassettes in the ADC manufacturing process.
相关内容
Learn more on mAb downstream processing, more specifically concentration and diafiltration, and the relevant associated products.
了解有关 mAb 下游加工（更具体地说是浓缩和重滤）以及相关产品的更多信息。
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持